Also, the INK4 Cdk-inhibitor p16 promotes cell migration in hepatocellular carcinoma cells through the activation of Rac1, although it has also been described that p16 plays a negative role on migration in other tumours39. This evidence concerns the gene CDKN2A and hepatocellular carcinoma.